ANKRD18A as a novel epigenetic regulation gene in lung cancer

Biochemical and Biophysical Research Communications

Volumn 429, Issue 3-4, 2012, Pages 180-185

  Liu, Wen Bin ^a   Han, Fei ^a   Jiang, Xiao ^a   Yang, Lu Jun ^b   Li, Yong Hong ^a   Liu, Yong ^a   Chen, Hong Qiang ^a   Ao, Lin ^a   Cui, Zhi Hong ^a   Cao, Jia ^a   Liu, Jin Yi ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b Chongqing Institute of Science and Technology for Population and Family Planning   (China)

Author keywords

ANKRD18A; DNA methylation; Epigenetic regulation; Lung cancer

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; ANKYRIN; ANKYRIN 18A; MESSENGER RNA; UNCLASSIFIED DRUG;

ANKRD18A GENE; ARTICLE; CANCER CELL; CANCER TISSUE; CONTROLLED STUDY; DEMETHYLATION; DNA METHYLATION; DOWN REGULATION; GENE; GENE EXPRESSION REGULATION; GENETIC SCREENING; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG CANCER; LUNG PARENCHYMA; PRIORITY JOURNAL; PROMOTER REGION;

ANKYRIN REPEAT; AZACITIDINE; DNA METHYLATION; DNA MODIFICATION METHYLASES; DOWN-REGULATION; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; PROMOTER REGIONS, GENETIC;

EID: 84870654685     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.10.116     Document Type: Article

References (23)

1. Siegel R., Naishadham D., Jemal A. Cancer statistics, 2012. CA: Cancer J. Clin. 2012, 62:10-29.
2. Feil R., Fraga M.F. Epigenetics and the environment: emerging patterns and implications. Nat. Rev. Genet. 2012, 13:97-109.
3. Rodríguez-Paredes M., Esteller M. Cancer epigenetics reaches mainstream oncology. Nat. Med. 2011, 17:330-339.
4. Sharma S., Kelly T.K., Jones P.A. Epigenetics in cancer. Carcinogenesis 2010, 31:27-36.
5. Xu L., Li X., Chu E.S., Zhao G., Go M.Y., Tao Q., Jin H., Zeng Z., Sung J.J., Yu J. Epigenetic inactivation of BCL6B, a novel functional tumour suppressor for gastric cancer, is associated with poor survival of gastric cancer. Gut 2012, 61:977-985.
6. Liu W., Li X., Chu E.S., Go M.Y., Xu L., Zhao G., Li L., Dai N., Si J., Tao Q., Sung J.J., Yu J. Paired box gene 5 is a novel tumor suppressor in hepatocellular carcinoma through interaction with p53 signaling pathway. Hepatology 2011, 53:843-853.
7. Cheung K.F., Lam C.N., Wu K., Ng E.K., Chong W.W., Cheng A.S., To K.F., Fan D., Sung J.J., Yu J. Characterization of the gene structure, functional significance, and clinical application of RNF180, a novel gene in gastric cancer. Cancer 2012, 118:947-959.
8. Kimura K., Wakamatsu A., Suzuki Y., Ota T., Nishikawa T., Yamashita R., Yamamoto J., Sekine M., Tsuritani K., Wakaguri H., Ishii S., Sugiyama T., Saito K., Isono Y., Irie R., Kushida N., Yoneyama T., Otsuka R., Kanda K., Yokoi T., Kondo H., Wagatsuma M., Murakawa K., Ishida S., Ishibashi T., Takahashi-Fujii A., Tanase T., Nagai K., Kikuchi H., Nakai K., Isogai T., Sugano S. Diversification of transcriptional modulation: large-scale identification and characterization of putative alternative promoters of human genes. Genome Res. 2006, 16:55-65.
9. Strausberg R.L., Feingold E.A., Grouse L.H., Derge J.G., Klausner R.D., Collins F.S., Wagner L., Shenmen C.M., Schuler G.D., Altschul S.F., Zeeberg B., Buetow K.H., Schaefer C.F., Bhat N.K., Hopkins R.F., Jordan H., Moore T., Max S.I., Wang J., Hsieh F., Diatchenko L., Marusina K., Farmer A.A., Rubin G.M., Hong L., Stapleton M., Soares M.B., Bonaldo M.F., Casavant T.L., Scheetz T.E., Brownstein M.J., Usdin T.B., Toshiyuki S., Carninci P., Prange C., Raha S.S., Loquellano N.A., Peters G.J., Abramson R.D., Mullahy S.J., Bosak S.A., McEwan P.J., McKernan K.J., Malek J.A., Gunaratne P.H., Richards S., Worley K.C., Hale S., Garcia A.M., Gay L.J., Hulyk S.W., Villalon D.K., Muzny D.M., Sodergren E.J., Lu X., Gibbs R.A., Fahey J., Helton E., Ketteman M., Madan A., Rodrigues S., Sanchez A., Whiting M., Madan A., Young A.C., Shevchenko Y., Bouffard G.G., Blakesley R.W., Touchman J.W., Green E.D., Dickson M.C., Rodriguez A.C., Grimwood J., Schmutz J., Myers R.M., Butterfield Y.S., Krzywinski M.I., Skalska U., Smailus D.E., Schnerch A., Schein J.E., Jones S.J., Marra M.A. Mammalian gene collection program team., generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences. Proc. Natl. Acad. Sci. USA 2002, 99:16899-16903.
10. Sedgwick S.G., Smerdon S.J. The ankyrin repeat: a diversity of interactions on a common structural framework. Trends Biochem. Sci. 1999, 24:311-316.
11. Liu Y., An Q., Li L., Zhang D., Huang J., Feng X., Cheng S., Gao Y. Hypermethylation of p16INK4a in Chinese lung cancer patients: biological and clinical implications. Carcinogenesis 2003, 24:1897-1901.
12. Zhao J., Wu G., Bu F., Lu B., Liang A., Cao L., Tong X., Lu X., Wu M., Guo Y. Epigenetic silence of ankyrin-repeat-containing, SH3-domain-containing, and proline-rich-region- containing protein 1 (ASPP1) and ASPP2 genes promotes tumor growth in hepatitis B virus-positive hepatocellular carcinoma. Hepatology 2010, 51:142-153.
13. Sarkar S., Roy B.C., Hatano N., Aoyagi T., Gohji K., Kiyama R. A novel ankyrin repeat-containing gene (Kank) located at 9p24 is a growth suppressor of renal cell carcinoma. J. Biol. Chem. 2002, 277:36585-36591.
14. Zhang L., Anglesio M.S., O'Sullivan M., Zhang F., Yang G., Sarao R., Mai P.N., Cronin S., Hara H., Melnyk N., Li L., Wada T., Liu P.P., Farrar J., Arceci R.J., Sorensen P.H., Penninger J.M. The E3 ligase HACE1 is a critical chromosome 6q21 tumor suppressor involved in multiple cancers. Nat. Med. 2007, 13:1060-1069.
15. Liu W.B., Liu J.Y., Ao L., Zhou Z.Y., Zhou Y.H., Cui Z.H., Yang H., Cao J. Dynamic changes in DNA methylation during multistep rat lung carcinogenesis induced by 3-methylcholanthrene and diethylnitrosamine. Toxicol. Lett. 2009, 189:5-13.
16. Liu W.B., Cui Z.H., Ao L., Zhou Z.Y., Zhou Y.H., Yuan X.Y., Xiang Y.L., Liu J.Y., Cao J. Aberrant methylation accounts for cell adhesion-related gene silencing during 3-methylcholanthrene and diethylnitrosamine induced multistep rat lung carcinogenesis associated with overexpression of DNA methyltransferases 1 and 3a. Toxicol. Appl. Pharmacol. 2011, 251:70-78.
17. Li X., Cheung K.F., Ma X., Tian L., Zhao J., Go M.Y., Shen B., Cheng A.S., Ying J., Tao Q., Sung J.J., Kung H.F., Yu J. Epigenetic inactivation of paired box gene 5, a novel tumor suppressor gene, through direct upregulation of p53 is associated with prognosis in gastric cancer patients. Oncogene 2012, 31:3419-3430.
18. Yu J., Ma X., Cheung K.F., Li X., Tian L., Wang S., Wu C.W., Wu W.K., He M., Wang M., Ng S.S., Sung J.J. Epigenetic inactivation of T-box transcription factor 5, a novel tumor suppressor gene, is associated with colon cancer. Oncogene 2010, 29:6464-6474.
19. Das P.M., Thor A.D., Edgerton S.M., Barry S.K., Chen D.F., Jones F.E. Reactivation of epigenetically silenced HER4/ERBB4 results in apoptosis of breast tumor cells. Oncogene 2010, 29:5214-5219.
20. Scurr L.L., Guminski A.D., Chiew Y.E., Balleine R.L., Sharma R., Lei Y., Pryor K., Wain G.V., Brand A., Byth K., Kennedy C., Rizos H., Harnett P.R., deFazio A. Ankyrin repeat domain 1, ANKRD1, a novel determinant of cisplatin sensitivity expressed in ovarian cancer. Clin. Cancer Res. 2008, 14:6924-6932.
21. Tanno H., Yamaguchi T., Goto E., Ishido S., Komada M. The Ankrd 13 family of UIM-bearing proteins regulates EGF receptor endocytosis from the plasma membrane. Mol. Biol. Cell 2012, 23:1343-1353.
22. Sahab Z.J., Hall M.D., Me Sung Y., Dakshanamurthy S., Ji Y., Kumar D., Byers S.W. Tumor suppressor RARRES1 interacts with cytoplasmic carboxypeptidase AGBL2 to regulate the α-tubulin tyrosination cycle. Cancer Res. 2011, 71:1219-1228.
23. Liu X.F., Bera T.K., Kahue C., Escobar T., Fei Z., Raciti G.A., Pastan I. ANKRD26 and its interacting partners TRIO, GPS2, HMMR and DIPA regulate adipogenesis in 3T3-L1 cells. PLoS ONE 2012, 7:e38130.